Trial
NCT04751071
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sadat City University
Collaborators
—
Condition
Major Depressive Disorder
Intervention
Roflumilast 500Mcg Tab
Why stopped
Institutional and funding constrains
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-14